IVL challengers face a challenge: 90% physicians plan to stick with Shockwave
medintel surveyed 311 vascular surgeons and interventional radiologists across the US and EU in January 2026. 80% already use IVL. 92% plan to stay on Shockwave. Here's what the physician data says about the Stryker/AVS acquisition and Boston Scientific's Seismiq launch.
Intravascular Lithotripsy Holds Promise 2:1 Versus Absorbable Stents In PAD
Vascular surgeons and interventional radiologists, showed twice the level of enthusiasm for the innovation offered by Intravascular Lithotripsy than the next technology believed to show most promise, absorbable stents, in offering innovation in Peripheral Arterial Disease PAD treatment over the next three years.